-
CJ Blossom Park Named the Best New Laboratory in the World
Apr 24, 2018, 09:50 AM by Michael CroftLOS ANGELES - Apr 24, 2018 - CJ Blossom Park in Suwon, South Korea has won R&D Magazine's prestigious Lab of the Year AwardFull story -
CD Genomics Launches Premier RNA-Seq Service for Cost-efficient and Accurate Gene Expression Profiling
Apr 24, 2018, 04:46 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Apr 23, 2018 - Today CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the enhanced launch of its RNA-Seq service, which focuses on gene expression profiling with CD Genomics proprietary technical platformFull story -
NextGen Frontier for Digital Healthcare Marketing service by Plus Promo
Apr 24, 2018, 04:33 AM by Michael CroftPUNE, INDIA - Apr 24, 2018 - Plus Promo is a Digital Marketing Company which helps Pharmaceutical and Healthcare sector to establish and expand their Digital assets in Healthcare Market , healthcare events management, healthcare content development , brand reputation, Healthcare Web Portal Development Get More Information: http://pluspromoFull story -
Sterling Pharma Solutions experiences record US growth
Apr 23, 2018, 09:37 AM by Michael CroftCRAMLINGTON, UNITED KINGDOM - Apr 23, 2018 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has more than doubled its sales in the US over the last two yearsThe increase in sales forms part of the companys growth strategy, which is focused on key markets including the US, UK, Japan and EuropeFull story -
FAIR Data At The Right Time: What Researchers Are Saying About Data Stewardship
Apr 23, 2018, 09:00 AM by Michael CroftFull storyBio-IT World | There’s a movement afoot to make data more findable, accessible, interoperable and reusable. In a survey about data stewardship, Bio-IT World found that while data standards and sharing are widely considered important, most people still struggle with both.
-
Synpromics awarded Innovate UK grant to evaluate its inducible promoter platform in collaboration with Lonza Pharma & Biotech
Apr 23, 2018, 05:32 AM by Michael CroftEDINBURGH, UK - Apr 23, 2018 - Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticalsFull story -
Bio-IT World Announces Finalists For 2018 Best Practices Awards
Apr 20, 2018, 09:20 AM by Michael CroftFull storyBio-IT World | The finalists for the 2018 Bio-IT World Best Practices competition were announced today. This year, 21 projects from 30 different organizations were chosen for the final round of competition.
-
Sterling invests £6m in pilot plant facility
Apr 20, 2018, 09:12 AM by Michael CroftCRAMLINGTON, UNITED KINGDOM - Apr 19, 2018 - Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilitiesFull story -
Cambridge Innovation Institute Announces Acquisition Of The AI World Conference & Expo, AI Trends
Apr 18, 2018, 16:00 PM by Michael CroftFull storyBio-IT World Brief | Cambridge Innovation Institute (CII), the parent company of Bio-IT World, announced the acquisition of Westborough, Massachusetts-based Trends Equity, which includes the properties of the annual AI World Conference & Expo and AI Trends media offerings.
-
New 2D Superresolution mode for ZEISS Airyscan delivers 120 nanometer lateral resolution
Apr 17, 2018, 16:44 PM by Michael CroftBOSTON, MA, UNITED STATES - Apr 17, 2018 - New 2D Superresolution mode for ZEISS Airyscan delivers 120 nanometer lateral resolutionImproved optical sectioning delivers higher resolution without the need to acquire a z-stack JENA/Germany At Neuroscience 2017, a new imaging mode for the ZEISS LSM 8 family with Airyscan has been introducedFull story -
Bioclinica Announces Executive Hires and Promotion
Apr 17, 2018, 15:45 PM by Michael CroftPRINCETON, NJ, US - Apr 11, 2018 - Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, today announces two executive-level additions and one promotion, further strengthening and diversifying its executive leadership teamFull story -
Advanced Biotechnologies Releases Quantitated Viral RNA
Apr 17, 2018, 13:55 PM by Michael CroftELDERSBURG, MD - Apr 17, 2018 - Advanced Biotechnologies introduces their new line of Quantitated Viral RNA products suitable for use in clinical labs and research facilities requiring RNA extracted from highly-purified virusFull story -
Linguamatics Spring Text Mining Conference 2018 to Feature Speakers from Leading Biomedical Organizations
Apr 17, 2018, 12:16 PM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Apr 17, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, today announced its Spring Text Mining Conference 2018 will feature presentations from several top-tier biomedical organizationsFull story -
SeraCare Partners with NAVICAN on Implementation of Best-In-Class QC Workflow for TheraMap Precision Cancer Care™ Services
Apr 16, 2018, 12:30 PM by Michael CroftMILFORD, MA, UNITED STATES - Apr 17, 2018 - SeraCare Life Sciences has partnered with NAVICAN, an Intermountain Healthcare company, and Royal Philips on the integration of SeraCares leading clinical NGS QC solution to support the roll out of NAVICANs TheraMap Precision Cancer Care servicesFull story -
SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials
Apr 16, 2018, 09:22 AM by Michael CroftMILFORD, MA, UNITED STATES - Apr 16, 2018 - SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announces two new upcoming additions to the Seraseq™ Circulating Tumor DNA (ctDNA) portfolio of reference materials, ctDNA Complete™ and ctDNA PanelsFull story -
BioIVT to Discuss In Vitro Hepatic Models for Toxicity Studies at the AAPS Joint Workshop on Drug Transporters in ADME
Apr 16, 2018, 08:56 AM by Michael CroftWESTBURY, NY - Apr 16, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be participating in two sessions at the American Association of Pharmaceutical Scientists (AAPS) Joint Workshop on Drug Transporters in ADME: From The Bench To The BedsideFull story -
Social Media listening on Steglatro: Research and Study on Social Media Channels
Apr 16, 2018, 06:05 AM by Michael CroftPUNE, INDIA - Apr 16, 2018 - Research Study BackgroundOn 19th December 2017, FDA approves another robust anti-diabetic drug adjunct with diet and exercise name Steglatro (ertugliflozin) oral sodium-glucose cotransporter 2 (SGLT2) inhibitor by MerckFull story -
Data Science, AI, Genomics, & Much More: A Preview of #BioIT18
Apr 16, 2018, 06:00 AM by Michael CroftFull storyBio-IT World | Whether you are coming to tour the exhibit hall, watch the three awards programs, listen to the plenary speakers, participate in the Hackathon, or dig deep into the latest science you are sure to have a full and fruitful three days during the 2018 Bio-IT World Conference & Expo.
-
Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development
Apr 13, 2018, 08:17 AM by Michael CroftDiagnostics World News | Yesterday, FDA Commissioner Scott Gottlieb announced via Twitter new policies for the Administration he says are designed to "keep pace with fast-moving [next-generation sequencing] technologies." The three guidances focus solely on NGS and in vitro diagnostic development.Full story -
Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions
Apr 12, 2018, 16:57 PM by Michael CroftPRINCETON, NJ - Apr 12, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has acquired Analytica Laser, a global research consultancy that uses health economics and outcomes research (HEOR) and real-world data to provide the highest level of scientific evidence of the value of medicines and health technologiesFull story